Subscribe To
Enanta pharmaceuticals, inc. (enta) ceo dr. jay luly on q4 fiscal 2021 result - earnings call transcript
Enanta pharmaceuticals, Inc. (ENTA) CEO Dr. Jay Luly on Q4 Fiscal 2021 Result - Earnings Call Transcrip...
November 22, 2021, 9:47 pm
Enanta pharmaceuticals, inc. (enta) ceo dr. jay luly on q4 fiscal 2021 result - earnings call transcript
Enanta pharmaceuticals, Inc. (ENTA) CEO Dr. Jay Luly on Q4 Fiscal 2021 Result - Earnings Call Transcrip...
November 22, 2021, 9:47 pm
Enanta pharmaceuticals, inc. (enta) ceo dr. jay luly on q4 fiscal 2021 result - earnings call transcript
Enanta pharmaceuticals, Inc. (ENTA) CEO Dr. Jay Luly on Q4 Fiscal 2021 Result - Earnings Call Transcrip...
November 22, 2021, 9:47 pm
Read why analysts are going bullish on this large-cap pharma stock
RBC Capital has upgraded Alnylam pharmaceuticals Inc (NASDAQ: ALNY) to Outperform from Sector Perf...
November 22, 2021, 1:48 pm
Read why analysts are going bullish on this large-cap pharma stock
RBC Capital has upgraded Alnylam pharmaceuticals Inc (NASDAQ: ALNY) to Outperform from Sector Perf...
November 22, 2021, 1:48 pm
Read why analysts are going bullish on this large-cap pharma stock
RBC Capital has upgraded Alnylam pharmaceuticals Inc (NASDAQ: ALNY) to Outperform from Sector Perf...
November 22, 2021, 1:48 pm
Why aurinia pharmaceuticals stock crashed in after-hours trading on friday
A $250 mixed shelf offering isn't sitting well with the biotech's shareholders....
November 20, 2021, 8:45 am
Why aurinia pharmaceuticals stock crashed in after-hours trading on friday
A $250 mixed shelf offering isn't sitting well with the biotech's shareholders....
November 20, 2021, 8:45 am
Why aurinia pharmaceuticals stock crashed in after-hours trading on friday
A $250 mixed shelf offering isn't sitting well with the biotech's shareholders....
November 20, 2021, 8:45 am
Syros pharmaceuticals is a buy as new trials start
Tamibarotene Phase 2 AML data is expected in 2022. Positive trial AML or MDS data would lead to an application to the FDA in 2024....
November 19, 2021, 7:54 pm
Syros pharmaceuticals is a buy as new trials start
Tamibarotene Phase 2 AML data is expected in 2022. Positive trial AML or MDS data would lead to an application to the FDA in 2024....
November 19, 2021, 7:54 pm
Syros pharmaceuticals is a buy as new trials start
Tamibarotene Phase 2 AML data is expected in 2022. Positive trial AML or MDS data would lead to an application to the FDA in 2024....
November 19, 2021, 7:54 pm
Novo nordisk enhances metabolic disorder pipeline with rnai drug maker dicerna
Novo Nordisk paid $3.3 billion to acquire RNAi drug maker Dicerna pharmaceuticals. Acquisition of Dicer...
November 18, 2021, 8:14 pm
Novo nordisk enhances metabolic disorder pipeline with rnai drug maker dicerna
Novo Nordisk paid $3.3 billion to acquire RNAi drug maker Dicerna pharmaceuticals. Acquisition of Dicer...
November 18, 2021, 8:14 pm
Novo nordisk enhances metabolic disorder pipeline with rnai drug maker dicerna
Novo Nordisk paid $3.3 billion to acquire RNAi drug maker Dicerna pharmaceuticals. Acquisition of Dicer...
November 18, 2021, 8:14 pm
Mirum pharmaceuticals, inc. (mirm) ceo chris peetz on q3 2021 results - earnings call transcript
Mirum pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q3 2021 Results - Earnings Call Transcript...
November 16, 2021, 12:08 am
Mirum pharmaceuticals, inc. (mirm) ceo chris peetz on q3 2021 results - earnings call transcript
Mirum pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q3 2021 Results - Earnings Call Transcript...
November 16, 2021, 12:08 am
Mirum pharmaceuticals, inc. (mirm) ceo chris peetz on q3 2021 results - earnings call transcript
Mirum pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q3 2021 Results - Earnings Call Transcript...
November 16, 2021, 12:08 am
Tff pharmaceuticals, inc. (tffp) ceo glenn mattes on q3 2021 results - earnings call transcript
TFF pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q3 2021 Results - Earnings Call Transcript...
November 15, 2021, 11:14 pm
Tff pharmaceuticals, inc. (tffp) ceo glenn mattes on q3 2021 results - earnings call transcript
TFF pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q3 2021 Results - Earnings Call Transcript...
November 15, 2021, 11:14 pm